Kobayashi Pharmaceutical Co. , the Japanese health products company that was at the center of a supplement contamination scandal involving suspected deaths, is said to be considering a potential buyout offer of more than ¥500 billion ($3. 2 billion) by private equity investors.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-09-24/kobayashi-in-3-2-billion-buyout-talks-after-red-yeast-scandal)